Nova Eye Medical Limited
ELXMF
$0.10
-$0.086-46.24%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.74% | -73.29% | -0.20% | 43.22% | 0.48% |
| Total Depreciation and Amortization | -2.75% | -64.05% | 0.19% | 187.08% | -0.50% |
| Total Amortization of Deferred Charges | -2.71% | -- | -- | -- | -0.49% |
| Total Other Non-Cash Items | -2.77% | 497.51% | -0.18% | -606.31% | 0.00% |
| Change in Net Operating Assets | -- | -- | -0.22% | -- | -- |
| Cash from Operations | 2.75% | 2.70% | -0.20% | 9.53% | 0.48% |
| Capital Expenditure | 2.88% | -457.14% | 0.00% | 91.14% | 0.47% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.84% | -192.76% | 0.66% | 142.18% | 0.56% |
| Cash from Investing | 2.65% | -570.83% | 1.05% | 109.59% | 0.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -91.30% | 0.00% | 44.91% | 0.00% |
| Issuance of Common Stock | -- | -- | 0.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.71% | -104.94% | 0.21% | 2,289.89% | 0.55% |
| Foreign Exchange rate Adjustments | -2.79% | 8,085.71% | 0.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.74% | -211.84% | 0.21% | 174.29% | 0.48% |